心力衰竭的新型组合疗法:通过协同网络虚拟查和实验验证识别了trimebutine-methoxsalen
Yunyuan Huang1, Xin Chen2, Jin Yang3
1Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, Hubei 430079, China.
Journal of chemical information and modeling
|September 11, 2024
概括
研究人员使用计算药物发现方法确定了一种新的心力衰竭治疗方法. 三叶素-甲索萨伦组合通过减少过载和氧化应激,显示出心脏保护作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 心血管研究研究心血管研究
背景情况:
- 组合疗法是发现复杂疾病有效治疗的首选策略.
- 以前的计算方法确定了药物组合,但缺乏机械洞察力.
研究的目的:
- 完善计算查,以识别协同作用药物组合及其机制.
- 为了研究三卜素-甲索萨林组合治疗心力衰竭 (HF) 的潜力.
主要方法:
- 过渡到最高单个代理 (HSA) 协同效应模型用于网络选.
- 在体外和体内评估了trimebutine-methoxsalen组合的心脏保护作用.
- 对细胞内和活性氧物种 (ROS) 水平进行了机制研究.
主要成果:
- 特里姆布丁 - 甲索萨伦组合在体外表现出显著的心脏保护作用.
- 这种组合有效地缓解了小鼠心脏中因异二醇 (ISO) 引起的结构重塑.
- 观察到协同抑制细胞内过载和减少ROS产量.
结论:
- 为识别新型组合疗法及其机制,开发了一种先进的计算策略.
- 特里姆布丁 - 甲索萨伦组合代表了对心力衰竭的有前途的新疗法.
- 心脏保护作用归因于对过载和ROS产生的协同抑制.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
01:26Heart Failure Drugs: Inotropic Agents
543
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
543
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K